Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

IGC Pharma (IGC) Change in Receivables (2016 - 2025)

IGC Pharma has reported Change in Receivables over the past 16 years, most recently at $7000.0 for Q3 2025.

Quarterly Change in Receivables rose 40.0% to $7000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Sep 2025, up 102.94% year-over-year, with the annual reading at $8000.0 for FY2025, 102.54% up from the prior year.
Change in Receivables was $7000.0 for Q3 2025 at IGC Pharma, up from -$2000.0 in the prior quarter.
Over five years, Change in Receivables peaked at $324000.0 in Q1 2022 and troughed at -$301000.0 in Q1 2024.
The 5-year median for Change in Receivables is $5000.0 (2024), against an average of -$117.65.
Year-over-year, Change in Receivables plummeted 675.0% in 2021 and then soared 3800.0% in 2022.
A 5-year view of Change in Receivables shows it stood at $2000.0 in 2021, then soared by 3800.0% to $78000.0 in 2022, then plummeted by 156.41% to -$44000.0 in 2023, then skyrocketed by 111.36% to $5000.0 in 2024, then soared by 40.0% to $7000.0 in 2025.
Per Business Quant, the three most recent readings for IGC's Change in Receivables are $7000.0 (Q3 2025), -$2000.0 (Q1 2025), and $5000.0 (Q4 2024).